Literature DB >> 19187006

Different redox states in malignant and nonmalignant esophageal epithelial cells and differential cytotoxic responses to bile acid and honokiol.

Gang Chen1, Julie Izzo, Yusuke Demizu, Feng Wang, Sushovan Guha, Xifeng Wu, Mein-Chie Hung, Jaffer A Ajani, Peng Huang.   

Abstract

Esophageal adenocarcinoma (EAC) is a highly lethal cancer in western countries. EAC cells are believed to develop from esophageal epithelial cells through complex transformation processes involving inflammation and oxidative stress. The purpose of this study was to compare the redox status of malignant and nonmalignant esophageal epithelial cells and to test their responses to bile acid-induced oxidative stress and to treatment with honokiol (HNK), a natural product with anticancer activity. We demonstrated that esophageal adenocarcinoma cells express significantly higher levels of antioxidant molecules and were resistant to reactive oxygen species (ROS) stress induced by bile acid, but were sensitive to the cytotoxic action of HNK. Mechanistic study showed that HNK caused cancer cell death by disruption of mitochondrial transmembrane potential and was correlated with cyclophilin D (CypD) expression. Inhibition of CypD by cyclosporin A or abrogation of its expression by siRNA significantly suppressed the cytotoxicity of HNK, suggesting that CypD may be a key molecule that mediates the cytotoxicity. Our study suggests that the high antioxidant capacity in EAC cells confers on them the ability to survive the oxidative microenvironment in the reflux esophagus, and that HNK is a promising compound to kill the transformed cells preferentially.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19187006      PMCID: PMC2842128          DOI: 10.1089/ars.2008.2321

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  55 in total

Review 1.  Mitochondria: a target for cancer therapy.

Authors:  Jeffrey S Armstrong
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

2.  Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.

Authors:  Anfernee Kai-Wing Tse; Chi-Keung Wan; Xiao-Ling Shen; Mengsu Yang; Wang-Fun Fong
Journal:  Biochem Pharmacol       Date:  2005-09-21       Impact factor: 5.858

3.  Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis.

Authors:  Kenji Ishitsuka; Teru Hideshima; Makoto Hamasaki; Noopur Raje; Shaji Kumar; Hiromasa Hideshima; Norihiko Shiraishi; Hiroshi Yasui; Aldo M Roccaro; Paul Richardson; Klaus Podar; Steven Le Gouill; Dharminder Chauhan; Kazuo Tamura; Jack Arbiser; Kenneth C Anderson
Journal:  Blood       Date:  2005-05-03       Impact factor: 22.113

Review 4.  Reflux injury of esophageal mucosa: experimental studies in animal models of esophagitis, Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Yan Li; Robert C G Martin
Journal:  Dis Esophagus       Date:  2007       Impact factor: 3.429

Review 5.  Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1.

Authors:  Gregg L Semenza
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

Review 6.  Esophageal adenocarcinoma and Barrett's esophagus.

Authors:  H Sayana; S Wani; P Sharma
Journal:  Minerva Gastroenterol Dietol       Date:  2007-06

7.  High cyclophilin D content of synaptic mitochondria results in increased vulnerability to permeability transition.

Authors:  Kranthi Kumari Naga; Patrick G Sullivan; James W Geddes
Journal:  J Neurosci       Date:  2007-07-11       Impact factor: 6.167

8.  Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity.

Authors:  Eun-Ryeong Hahm; Shivendra V Singh
Journal:  Mol Cancer Ther       Date:  2007-10       Impact factor: 6.261

Review 9.  Novel findings in the pathogenesis of esophageal columnar metaplasia or Barrett's esophagus.

Authors:  Kausilia K Krishnadath
Journal:  Curr Opin Gastroenterol       Date:  2007-07       Impact factor: 3.287

10.  Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure.

Authors:  Ying Hao; Sumita Sood; George Triadafilopoulos; Jong Hyeok Kim; Zheng Wang; Peyman Sahbaie; M Bishr Omary; Anson W Lowe
Journal:  BMC Gastroenterol       Date:  2007-06-27       Impact factor: 3.067

View more
  14 in total

1.  A novel synthetic C-1 analogue of 7-deoxypancratistatin induces apoptosis in p53 positive and negative human colorectal cancer cells by targeting the mitochondria: enhancement of activity by tamoxifen.

Authors:  Dennis Ma; Phillip Tremblay; Kevinjeet Mahngar; Pardis Akbari-Asl; Jonathan Collins; Tomas Hudlicky; James McNulty; Siyaram Pandey
Journal:  Invest New Drugs       Date:  2011-04-15       Impact factor: 3.850

Review 2.  Small mitochondria-targeting molecules as anti-cancer agents.

Authors:  Feng Wang; Marcia A Ogasawara; Peng Huang
Journal:  Mol Aspects Med       Date:  2009-12-06

Review 3.  Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds.

Authors:  Gang Chen; Feng Wang; Dunyaporn Trachootham; Peng Huang
Journal:  Mitochondrion       Date:  2010-08-14       Impact factor: 4.160

4.  Cyclophilin D counteracts P53-mediated growth arrest and promotes Ras tumorigenesis.

Authors:  A Bigi; E Beltrami; M Trinei; M Stendardo; P G Pelicci; M Giorgio
Journal:  Oncogene       Date:  2016-03-14       Impact factor: 9.867

5.  Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells.

Authors:  Chunhua Yu; Qiuyang Zhang; Hui Ying Zhang; Xi Zhang; Xiaofang Huo; Edaire Cheng; David H Wang; Jack L Arbiser; Stuart Jon Spechler; Rhonda F Souza
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-28       Impact factor: 4.052

6.  Single-cell analysis reveals early manifestation of cancerous phenotype in pre-malignant esophageal cells.

Authors:  Jiangxin Wang; Xu Shi; Roger H Johnson; Laimonas Kelbauskas; Weiwen Zhang; Deirdre R Meldrum
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

7.  Overproduction of reactive oxygen species - obligatory or not for induction of apoptosis by anticancer drugs.

Authors:  Donika Ivanova; Zhivko Zhelev; Ichio Aoki; Rumiana Bakalova; Tatsuya Higashi
Journal:  Chin J Cancer Res       Date:  2016-08       Impact factor: 5.087

8.  Honokiol induces reactive oxygen species-mediated apoptosis in Candida albicans through mitochondrial dysfunction.

Authors:  Lingmei Sun; Kai Liao; Chengcheng Hang; Dayong Wang
Journal:  PLoS One       Date:  2017-02-13       Impact factor: 3.240

9.  Warburg and Crabtree effects in premalignant Barrett's esophagus cell lines with active mitochondria.

Authors:  Martin T Suchorolski; Thomas G Paulson; Carissa A Sanchez; David Hockenbery; Brian J Reid
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

10.  Cyclophilin 40 alters UVA-induced apoptosis and mitochondrial ROS generation in keratinocytes.

Authors:  Jana Jandova; Jaroslav Janda; James E Sligh
Journal:  Exp Cell Res       Date:  2012-12-03       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.